Clinical Trial Update: PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing the fixed-dose combination YH22162 with a separate telmisartan/amlodipine plus chlorthalidone regimen for hypertension; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Hygroton (chlorthalidone)
• Twynsta (telmisartan/amlodipine)
• YH22162 FDC (YH22162)

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension | Phase 1 | Status: COMPLETED